| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
McLoughlin Margaret is a Director at Quince Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $8K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | QNCX Quince Therapeutics, Inc. | Director | Buy | 8,000 | $1.23 | $9,840.00 | New | -21.3% | -43.4% | |
| Oct 8, 2021 | QNCX Quince Therapeutics, Inc. | Director | Sale+OE | 1,000 | $88.93 | $88,930.00 | -100% | -86.4% | -98.7% | |
| Aug 16, 2021 | QNCX Quince Therapeutics, Inc. | Director | Sale+OE | 6,000 | $95.44 | $572,643.52 | -52.8% | -84.4% | -97.7% | |
| Jun 28, 2021 | QNCX Quince Therapeutics, Inc. | Director | Sell | 550 | $55.15 | $30,332.50 | -55.0% | +72.2% | -95.8% | |
| May 13, 2019 | QNCX Quince Therapeutics, Inc. | Director | Buy | 550 | $17.00 | $9,350.00 | New | - | - |